Form 8-K - Current report:
SEC Accession No. 0001102624-16-002044
Filing Date
2016-01-29
Accepted
2016-01-29 06:19:11
Documents
2
Period of Report
2016-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucellcorporation8k.htm 8-K 10675
2 PRESS RELEASE exhibit99.htm EX-99 7053
  Complete submission text file 0001102624-16-002044.txt   18815
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 161370889
SIC: 2835 In Vitro & In Vivo Diagnostic Substances